Skip to main content
Top

21-03-2024 | ICD Infection | Original Article

Outcome and microbiological findings of patients with cardiac implantable electronic device infection

Authors: Lara C. Schipmann, Viviane Moeller, Juliane Krimnitz, Marwin Bannehr, Tobias Siegfried Kramer, Anja Haase-Fielitz, Christian Butter

Published in: Heart and Vessels

Login to get access

Abstract

Introduction

Infections associated with cardiac implantable electronic devices (CIEDs) are a multifactorial disease that leads to increased morbidity and mortality.

Objective

The aim was to analyze patient-, disease- and treatment-related characteristics including microbiological and bacterial spectrum according to survival status and to identify risk factors for 1- and 3-year mortality in patients with local and systemic CIED infection.

Methods

In a retrospective cohort study, we analyzed data from patients with CIED-related local or systemic infection undergoing successful transvenous lead extraction (TLE). Survival status as well as incidence and cause of rehospitalization were recorded. Microbiology and antibiotics used as first-line therapy were compared according to mortality. Independent risk factors for 1- and 3-year mortality were determined.

Results

Data from 243 Patients were analyzed. In-hospital mortality was 2.5%. Mortality rates at 30 days, 1- and 3 years were 4.1%, 18.1% and 30%, respectively. Seventy-four (30.5%) patients had systemic bacterial infection. Independent risk factors for 1-year mortality included age (OR 1.05 [1.01–1.10], p = 0.014), NT-proBNP at admission (OR 4.18 [1.81–9.65], p = 0.001), new onset or worsened tricuspid regurgitation after TLE (OR 6.04 [1.58–23.02], p = 0.009), and systemic infection (OR 2.76 [1.08–7.03], p = 0.034), whereas systemic infection was no longer an independent risk factor for 3-year mortality. Staphylococcus aureus was found in 18.1% of patients who survived and in 25% of those who died, p = 0.092. There was a high proportion of methicillin-resistant strains among coagulase-negative staphylococci (16.5%) compared to Staphylococcus aureus (1.2%).

Conclusions

Staphylococci are the most common causative germs of CIED-infection with coagulase-negative staphylococci showing higher resistance rates to antibiotics. The independent risk factors for increased long-term mortality could contribute to individual risk stratification and well-founded treatment decisions in clinical routine. Especially the role of tricuspid regurgitation as a complication after TLE should be investigated in future studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mond HG, Proclemer A (2011) The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009—a World Society of Arrhythmia’s project. Pacing Clin Electrophysiol 34:1013–1027CrossRefPubMed Mond HG, Proclemer A (2011) The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009—a World Society of Arrhythmia’s project. Pacing Clin Electrophysiol 34:1013–1027CrossRefPubMed
2.
go back to reference Bongiorni MG, Burri H, Deharo JC, Starck C, Kennergren C, Saghy L, Rao A, Tascini C, Lever N, Kutarski A, Fernandez Lozano I, Strathmore N, Costa R, Epstein L, Love C, Blomstrom-Lundqvist C, ESC Scientific Document Group (2018) 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. Europace 20:1217CrossRefPubMed Bongiorni MG, Burri H, Deharo JC, Starck C, Kennergren C, Saghy L, Rao A, Tascini C, Lever N, Kutarski A, Fernandez Lozano I, Strathmore N, Costa R, Epstein L, Love C, Blomstrom-Lundqvist C, ESC Scientific Document Group (2018) 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. Europace 20:1217CrossRefPubMed
3.
go back to reference Miyagi Y, Sakamoto SI, Kawase Y, Oomori H, Watanabe Y, Kurita J, Maruyama Y, Sasaki T, Ishii Y (2021) Temporal and microbiological analysis of cardiac implantable electrical device infections—a retrospective study. Circ Rep 3:488–496CrossRefPubMedPubMedCentral Miyagi Y, Sakamoto SI, Kawase Y, Oomori H, Watanabe Y, Kurita J, Maruyama Y, Sasaki T, Ishii Y (2021) Temporal and microbiological analysis of cardiac implantable electrical device infections—a retrospective study. Circ Rep 3:488–496CrossRefPubMedPubMedCentral
4.
go back to reference Le KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, Wilson WR, Steckelberg JM, Baddour LM, Mayo Cardiovascular Infections Study Group (2011) Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin Electrophysiol 34:450–459CrossRefPubMed Le KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, Wilson WR, Steckelberg JM, Baddour LM, Mayo Cardiovascular Infections Study Group (2011) Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin Electrophysiol 34:450–459CrossRefPubMed
5.
go back to reference Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, Poole J, Boriani G, Costa R, Deharo JC, Epstein LM, Saghy L, Snygg-Martin U, Starck C, Tascini C, Strathmore N, ESC Scientific Document Group (2020) European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace 22:515–549CrossRefPubMed Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, Poole J, Boriani G, Costa R, Deharo JC, Epstein LM, Saghy L, Snygg-Martin U, Starck C, Tascini C, Strathmore N, ESC Scientific Document Group (2020) European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace 22:515–549CrossRefPubMed
6.
go back to reference Olsen T, Jørgensen OD, Nielsen JC, Thøgersen AM, Philbert BT, Frausing MHJP, Sandgaard NCF, Johansen JB (2022) Risk factors for cardiac implantable electronic device infections: a nationwide Danish study. Eur Heart J 43:4946–4956CrossRefPubMedPubMedCentral Olsen T, Jørgensen OD, Nielsen JC, Thøgersen AM, Philbert BT, Frausing MHJP, Sandgaard NCF, Johansen JB (2022) Risk factors for cardiac implantable electronic device infections: a nationwide Danish study. Eur Heart J 43:4946–4956CrossRefPubMedPubMedCentral
7.
go back to reference Krahn AD, Longtin Y, Philippon F, Birnie DH, Manlucu J, Angaran P, Rinne C, Coutu B, Low RA, Essebag V, Morillo C, Redfearn D, Toal S, Becker G, Degrâce M, Thibault B, Crystal E, Tung S, LeMaitre J, Sultan O, Bennett M, Bashir J, Ayala-Paredes F, Gervais P, Rioux L, Hemels MEW, Bouwels LHR, van Vlies B, Wang J, Exner DV, Dorian P, Parkash R, Alings M, Connolly SJ (2018) Prevention of arrhythmia device infection trial: the PADIT trial. J Am Coll Cardiol 72:3098–3109CrossRefPubMed Krahn AD, Longtin Y, Philippon F, Birnie DH, Manlucu J, Angaran P, Rinne C, Coutu B, Low RA, Essebag V, Morillo C, Redfearn D, Toal S, Becker G, Degrâce M, Thibault B, Crystal E, Tung S, LeMaitre J, Sultan O, Bennett M, Bashir J, Ayala-Paredes F, Gervais P, Rioux L, Hemels MEW, Bouwels LHR, van Vlies B, Wang J, Exner DV, Dorian P, Parkash R, Alings M, Connolly SJ (2018) Prevention of arrhythmia device infection trial: the PADIT trial. J Am Coll Cardiol 72:3098–3109CrossRefPubMed
8.
go back to reference Tarakji KG, Mittal S, Kennergren C, Corey R, Poole JE, Schloss E, Gallastegui J, Pickett RA, Evonich R, Philippon F, McComb JM, Roark SF, Sorrentino D, Sholevar D, Cronin E, Berman B, Riggio D, Biffi M, Khan H, Silver MT, Collier J, Eldadah Z, Wright DJ, Lande JD, Lexcen DR, Cheng A, Wilkoff BL, WRAP-IT Investigators (2019) Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med 380:1895–1905CrossRefPubMed Tarakji KG, Mittal S, Kennergren C, Corey R, Poole JE, Schloss E, Gallastegui J, Pickett RA, Evonich R, Philippon F, McComb JM, Roark SF, Sorrentino D, Sholevar D, Cronin E, Berman B, Riggio D, Biffi M, Khan H, Silver MT, Collier J, Eldadah Z, Wright DJ, Lande JD, Lexcen DR, Cheng A, Wilkoff BL, WRAP-IT Investigators (2019) Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med 380:1895–1905CrossRefPubMed
9.
go back to reference Brunner MP, Yu C, Hussein AA, Tarakji KG, Wazni OM, Kattan MW, Wilkoff BL (2015) Nomogram for predicting 30-day all-cause mortality after transvenous pacemaker and defibrillator lead extraction. Heart Rhythm 12:2381–2386CrossRefPubMed Brunner MP, Yu C, Hussein AA, Tarakji KG, Wazni OM, Kattan MW, Wilkoff BL (2015) Nomogram for predicting 30-day all-cause mortality after transvenous pacemaker and defibrillator lead extraction. Heart Rhythm 12:2381–2386CrossRefPubMed
10.
go back to reference Deshmukh A, Patel N, Noseworthy PA, Patel AA, Patel N, Arora S, Kapa S, Noheria A, Mulpuru S, Badheka A, Fischer A, Coffey JO, Cha YM, Friedman P, Asirvatham S, Viles-Gonzalez JF (2015) Trends in use and adverse outcomes associated with transvenous lead removal in the United States. Circulation 132:2363–2371CrossRefPubMed Deshmukh A, Patel N, Noseworthy PA, Patel AA, Patel N, Arora S, Kapa S, Noheria A, Mulpuru S, Badheka A, Fischer A, Coffey JO, Cha YM, Friedman P, Asirvatham S, Viles-Gonzalez JF (2015) Trends in use and adverse outcomes associated with transvenous lead removal in the United States. Circulation 132:2363–2371CrossRefPubMed
11.
go back to reference Mehta VS, Elliott MK, Sidhu BS, Gould J, Kemp T, Vergani V, Kadiwar S, Shetty AK, Blauth C, Gill J, Bosco P, Rinaldi CA (2021) Long-term survival following transvenous lead extraction: importance of indication and comorbidities. Heart Rhythm 18:1566–1576CrossRefPubMed Mehta VS, Elliott MK, Sidhu BS, Gould J, Kemp T, Vergani V, Kadiwar S, Shetty AK, Blauth C, Gill J, Bosco P, Rinaldi CA (2021) Long-term survival following transvenous lead extraction: importance of indication and comorbidities. Heart Rhythm 18:1566–1576CrossRefPubMed
12.
go back to reference Oszczygieł E, Kutarski A, Oszczygieł A, Mańkowska-Załuska B, Chudzik M, Wranicz JK, Cygankiewicz I (2017) Risk score to assess mortality risk in patients undergoing transvenous lead extraction. Pacing Clin Electrophysiol 40:918–923CrossRefPubMed Oszczygieł E, Kutarski A, Oszczygieł A, Mańkowska-Załuska B, Chudzik M, Wranicz JK, Cygankiewicz I (2017) Risk score to assess mortality risk in patients undergoing transvenous lead extraction. Pacing Clin Electrophysiol 40:918–923CrossRefPubMed
13.
go back to reference Sood N, Martin DT, Lampert R, Curtis JP, Parzynski C, Clansy J (2018) Incidence and predictors of perioperative complications with transvenous lead extractions: real-world experience with national cardiovascular data registry. Circ Arrhythm Electrophysiol 11(2):e004768CrossRefPubMed Sood N, Martin DT, Lampert R, Curtis JP, Parzynski C, Clansy J (2018) Incidence and predictors of perioperative complications with transvenous lead extractions: real-world experience with national cardiovascular data registry. Circ Arrhythm Electrophysiol 11(2):e004768CrossRefPubMed
14.
go back to reference Wazni O, Epstein LM, Carrillo RG, Love C, Adler SW, Riggio DW, Karim SS, Bashir J, Greenspon AJ, DiMarco JP, Cooper JM, Onufer JR, Ellenbogen KA, Kutalek SP, Dentry-Mabry S, Ervin CM, Wilkoff BL (2010) Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol 55:579–586CrossRefPubMed Wazni O, Epstein LM, Carrillo RG, Love C, Adler SW, Riggio DW, Karim SS, Bashir J, Greenspon AJ, DiMarco JP, Cooper JM, Onufer JR, Ellenbogen KA, Kutalek SP, Dentry-Mabry S, Ervin CM, Wilkoff BL (2010) Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol 55:579–586CrossRefPubMed
15.
go back to reference El-Chami MF, Liu Y, Griffiths RI, Knight BP, Weiss R, Mark GE, Biffi M, Probst V, Lambiase PD, Miller MA, Jacobsen CM, Baddour LM (2022) Device-related infection associated with increased mortality risk in de novo transvenous implantable cardioverter-defibrillator medicare patients. J Cardiovasc Electrophysiol 33:725–730CrossRefPubMed El-Chami MF, Liu Y, Griffiths RI, Knight BP, Weiss R, Mark GE, Biffi M, Probst V, Lambiase PD, Miller MA, Jacobsen CM, Baddour LM (2022) Device-related infection associated with increased mortality risk in de novo transvenous implantable cardioverter-defibrillator medicare patients. J Cardiovasc Electrophysiol 33:725–730CrossRefPubMed
16.
go back to reference Rizwan Sohail M, Henrikson CA, Jo Braid-Forbes M, Forbes KF, Lerner DJ (2015) Increased long-term mortality in patients with cardiovascular implantable electronic device infections. Pacing Clin Electrophysiol 38:231–239CrossRefPubMed Rizwan Sohail M, Henrikson CA, Jo Braid-Forbes M, Forbes KF, Lerner DJ (2015) Increased long-term mortality in patients with cardiovascular implantable electronic device infections. Pacing Clin Electrophysiol 38:231–239CrossRefPubMed
17.
go back to reference Chung DU, Burger H, Kaiser L, Osswald B, Bärsch V, Nägele H, Knaut M, Reichenspurner H, Gessler N, Willems S, Butter C, Pecha S, Hakmi S, GALLERY investigators (2023) Transvenous lead extraction in patients with systemic cardiac device-related infection-Procedural outcome and risk prediction: a GALLERY subgroup-analysis. Heart Rhythm 20(2):181–189CrossRefPubMed Chung DU, Burger H, Kaiser L, Osswald B, Bärsch V, Nägele H, Knaut M, Reichenspurner H, Gessler N, Willems S, Butter C, Pecha S, Hakmi S, GALLERY investigators (2023) Transvenous lead extraction in patients with systemic cardiac device-related infection-Procedural outcome and risk prediction: a GALLERY subgroup-analysis. Heart Rhythm 20(2):181–189CrossRefPubMed
18.
go back to reference Sandoe JA, Barlow G, Chambers JB, Gammage M, Guleri A, Howard P, Olson E, Perry JD, Prendergast BD, Spry MJ, Steeds RP, Tayebjee MH, Watkin R, British Society for Antimicrobial Chemotherapy, British Heart Rhythm Society, British Cardiovascular Society, British Heart Valve Society, British Society for Echocardiography (2015) Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother 70:325–359CrossRefPubMed Sandoe JA, Barlow G, Chambers JB, Gammage M, Guleri A, Howard P, Olson E, Perry JD, Prendergast BD, Spry MJ, Steeds RP, Tayebjee MH, Watkin R, British Society for Antimicrobial Chemotherapy, British Heart Rhythm Society, British Cardiovascular Society, British Heart Valve Society, British Society for Echocardiography (2015) Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother 70:325–359CrossRefPubMed
19.
go back to reference Polyzos KA, Konstantelias AA, Falagas ME (2015) Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace 17:767–777CrossRefPubMed Polyzos KA, Konstantelias AA, Falagas ME (2015) Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace 17:767–777CrossRefPubMed
20.
go back to reference Palmisano P, Accogli M, Zaccaria M, Luzzi G, Nacci F, Anaclerio M, Favale S (2013) Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy. Europace 15:531–540CrossRefPubMed Palmisano P, Accogli M, Zaccaria M, Luzzi G, Nacci F, Anaclerio M, Favale S (2013) Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy. Europace 15:531–540CrossRefPubMed
21.
go back to reference Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S, Uslan DZ (2014) Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation 130:1037–1043CrossRefPubMed Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S, Uslan DZ (2014) Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation 130:1037–1043CrossRefPubMed
22.
go back to reference Rao A, Garner D, Starck C, Kirkfeldt RE, Dagres N, Didier K, Montano N, Heidbuchel H (2020) Knowledge gaps, lack of confidence, and system barriers to guideline implementation among European physicians managing patients with CIED lead or infection complications: a European Heart Rhythm Association/European Society of Cardiology educational needs assessment survey. Europace 22:1743–1753CrossRefPubMed Rao A, Garner D, Starck C, Kirkfeldt RE, Dagres N, Didier K, Montano N, Heidbuchel H (2020) Knowledge gaps, lack of confidence, and system barriers to guideline implementation among European physicians managing patients with CIED lead or infection complications: a European Heart Rhythm Association/European Society of Cardiology educational needs assessment survey. Europace 22:1743–1753CrossRefPubMed
23.
go back to reference Bongiorni MG, Kennergren C, Butter C, Deharo JC, Kutarski A, Rinaldi CA, Romano SL, Maggioni AP, Andarala M, Auricchio A, Kuck KH, Blomström-Lundqvist C, ELECTRa Investigators, (2017) The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of transvenous lead extraction outcomes. Eur Heart J 38:2995–3005CrossRefPubMed Bongiorni MG, Kennergren C, Butter C, Deharo JC, Kutarski A, Rinaldi CA, Romano SL, Maggioni AP, Andarala M, Auricchio A, Kuck KH, Blomström-Lundqvist C, ELECTRa Investigators, (2017) The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of transvenous lead extraction outcomes. Eur Heart J 38:2995–3005CrossRefPubMed
24.
go back to reference Baman TS, Gupta SK, Valle JA, Yamada E (2009) Risk factors for mortality in patients with cardiac device-related infection. Circ Arrhythm Electrophysiol 2:129–134CrossRefPubMed Baman TS, Gupta SK, Valle JA, Yamada E (2009) Risk factors for mortality in patients with cardiac device-related infection. Circ Arrhythm Electrophysiol 2:129–134CrossRefPubMed
25.
go back to reference Athan E, Chu VH, Tattevin P, Selton-Suty C, Jones P, Naber C, Miró JM, Ninot S, Fernández-Hidalgo N, Durante-Mangoni E, Spelman D, Hoen B, Lejko-Zupanc T, Cecchi E, Thuny F, Hannan MM, Pappas P, Henry M, Fowler VG Jr, Crowley AL, Wang A, ICE-PCS Investigators (2012) Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA 307:1727–1735CrossRefPubMed Athan E, Chu VH, Tattevin P, Selton-Suty C, Jones P, Naber C, Miró JM, Ninot S, Fernández-Hidalgo N, Durante-Mangoni E, Spelman D, Hoen B, Lejko-Zupanc T, Cecchi E, Thuny F, Hannan MM, Pappas P, Henry M, Fowler VG Jr, Crowley AL, Wang A, ICE-PCS Investigators (2012) Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA 307:1727–1735CrossRefPubMed
26.
go back to reference Deharo JC, Quatre A, Mancini J, Khairy P, Le Dolley Y, Casalta JP, Peyrouse E, Prévôt S, Thuny F, Collart F, Raoult D, Habib G, Franceschi F (2012) Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study. Heart 98:724–731CrossRefPubMed Deharo JC, Quatre A, Mancini J, Khairy P, Le Dolley Y, Casalta JP, Peyrouse E, Prévôt S, Thuny F, Collart F, Raoult D, Habib G, Franceschi F (2012) Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study. Heart 98:724–731CrossRefPubMed
27.
go back to reference Habib A, Le KY, Baddour LM, Friedman PA, Hayes DL, Lohse CM, Wilson WR, Steckelberg JM, Sohail MR, Mayo Cardiovascular Infections Study Group (2013) Predictors of mortality in patients with cardiovascular implantable electronic device infections. Am J Cardiol 111:874–879CrossRefPubMed Habib A, Le KY, Baddour LM, Friedman PA, Hayes DL, Lohse CM, Wilson WR, Steckelberg JM, Sohail MR, Mayo Cardiovascular Infections Study Group (2013) Predictors of mortality in patients with cardiovascular implantable electronic device infections. Am J Cardiol 111:874–879CrossRefPubMed
28.
go back to reference Diemberger I, Biffi M, Lorenzetti S, Martignani C, Raffaelli E, Ziacchi M, Rapezzi C, Pacini D, Boriani G (2018) Predictors of long-term survival free from relapses after extraction of infected CIED. Europace 20:1018–1027CrossRefPubMed Diemberger I, Biffi M, Lorenzetti S, Martignani C, Raffaelli E, Ziacchi M, Rapezzi C, Pacini D, Boriani G (2018) Predictors of long-term survival free from relapses after extraction of infected CIED. Europace 20:1018–1027CrossRefPubMed
29.
go back to reference Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL, Kacet S, Lekieffre J (1997) Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 95:2098–2107CrossRefPubMed Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL, Kacet S, Lekieffre J (1997) Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 95:2098–2107CrossRefPubMed
30.
go back to reference Le KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, Wilson WR, Steckelberg JM, Baddour LM, Mayo Cardiovascular Infections Study Group (2011) Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm 8:1678–1685CrossRefPubMed Le KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, Wilson WR, Steckelberg JM, Baddour LM, Mayo Cardiovascular Infections Study Group (2011) Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm 8:1678–1685CrossRefPubMed
31.
go back to reference von Eiff C, Peters G, Heilmann C (2002) Pathogenesis of infections due to coagulasenegative staphylococci. Lancet Infect Dis 2:677–685CrossRef von Eiff C, Peters G, Heilmann C (2002) Pathogenesis of infections due to coagulasenegative staphylococci. Lancet Infect Dis 2:677–685CrossRef
33.
go back to reference Polewczyk A, Jacheć W, Polewczyk AM, Tomasik A, Janion M, Kutarski A (2017) Infectious complications in patients with cardiac implantable electronic devices: risk factors, prevention, and prognosis. Pol Arch Intern Med 127:597–607PubMed Polewczyk A, Jacheć W, Polewczyk AM, Tomasik A, Janion M, Kutarski A (2017) Infectious complications in patients with cardiac implantable electronic devices: risk factors, prevention, and prognosis. Pol Arch Intern Med 127:597–607PubMed
34.
go back to reference Santaguida PL, Don-Wauchope AC, Oremus M, McKelvie R, Ali U, Hill SA, Balion C, Booth RA, Brown JA, Bustamam A, Sohel N, Raina P (2014) BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review. Heart Fail Rev 19:453–470CrossRefPubMed Santaguida PL, Don-Wauchope AC, Oremus M, McKelvie R, Ali U, Hill SA, Balion C, Booth RA, Brown JA, Bustamam A, Sohel N, Raina P (2014) BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review. Heart Fail Rev 19:453–470CrossRefPubMed
35.
go back to reference Li H, Zeng Z, Cheng J, Hu G, Li Y, Wei L, Zhou Y, Ran P (2020) Prognostic role of NT-proBNP for in-hospital and 1-year mortality in patients with acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis 15:57–67CrossRefPubMedPubMedCentral Li H, Zeng Z, Cheng J, Hu G, Li Y, Wei L, Zhou Y, Ran P (2020) Prognostic role of NT-proBNP for in-hospital and 1-year mortality in patients with acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis 15:57–67CrossRefPubMedPubMedCentral
36.
go back to reference Birgersdotter-Green U, Dawood FZ (2018) Transvenous extraction of pacemaker and defibrillator leads and the risk of tricuspid valve regurgitation: making a case for thoughtful lead management. JACC Clin Electrophysiol 4:1429–1430CrossRefPubMed Birgersdotter-Green U, Dawood FZ (2018) Transvenous extraction of pacemaker and defibrillator leads and the risk of tricuspid valve regurgitation: making a case for thoughtful lead management. JACC Clin Electrophysiol 4:1429–1430CrossRefPubMed
Metadata
Title
Outcome and microbiological findings of patients with cardiac implantable electronic device infection
Authors
Lara C. Schipmann
Viviane Moeller
Juliane Krimnitz
Marwin Bannehr
Tobias Siegfried Kramer
Anja Haase-Fielitz
Christian Butter
Publication date
21-03-2024
Publisher
Springer Japan
Published in
Heart and Vessels
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-024-02380-y